Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Targeting IL-10 in Auto-immune Diseases.
Nurr1 reduction influences the onset of chronic EAE in mice.
Response to letter regarding article 'Fingolimod effects on left ventricular function in multiple sclerosis'.
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool.
Interictal interleukin-17A levels are elevated and correlate with seizure severity of epilepsy patients.
New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease.
IgGs containing λ- and κ-type light chains and of all subclasses (IgG1-IgG4) from the sera of patients with autoimmune diseases and viral and bacterial infections hydrolyze DNA.
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.
Acute retinal necrosis in multiple sclerosis: A neuroimmunologic challenge!
The impact of self-transcendence on physical health status promotion in multiple sclerosis patients attending peer support groups.
ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis.
Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.
Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis.
Biogen Reports Top-Line Results from Phase 3 Study Evaluating Natalizumab in Secondary Progressive MS
Neuromyelitis optica.
Errata Corrige: The Neuroradiology Journal 25: 17-21, 2012. Multiple Sclerosis Lesions in the Brain: Computer-Assisted Assessment of Lesion Load Dynamics on 3D FLAIR MR Images.
Environmental factors acting during development to influence MS risk: insights from animal studies.
Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.
Functions of NOD-Like Receptors in Human Diseases.
Multiple sclerosis in the Southern and Northern hemispheres: the month of birth at different latitudes has the same influence on the prevalence and progression of the disease in the Northern and Southern hemispheres?
Immune response to chemically modified proteome.
Depression as a predictor of occupational transition in a multiple sclerosis cohort.
Regulation of Experimental Autoimmune Encephalomyelitis by TPL-2 Kinase.
[Multiple sclerosis, neuromyelitis optica and spasticity: control of specific symptoms and quality of life].
Pages
« first
‹ previous
…
397
398
399
400
401
402
403
404
405
…
next ›
last »